| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/13/2005 | EP1553174A2 Enzymes and detergent compositons |
| 07/13/2005 | EP1553173A2 Enzymes and detergent compositions |
| 07/13/2005 | EP1552852A1 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 07/13/2005 | EP1552462A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 07/13/2005 | EP1552310A2 Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylyltransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
| 07/13/2005 | EP1552308A1 Demethylated and/or oxidized membrane dna and use thereof in the diagnostic of autoimmune diseases |
| 07/13/2005 | EP1552305A2 Polypeptide immobilization |
| 07/13/2005 | EP1552303A2 Biosensor |
| 07/13/2005 | EP1552301A2 Methods of screening cyclic peptides and identifying targets therefor |
| 07/13/2005 | EP1552299A2 Method for the identification of ligands |
| 07/13/2005 | EP1552293A2 Gene segregation and biological sample classification methods |
| 07/13/2005 | EP1552276A1 A disposable cartridge for characterizing particles suspended in a liquid |
| 07/13/2005 | EP1552269A2 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 07/13/2005 | EP1552025A2 Processes for identifying quadruplex-targeted antiviral molecules |
| 07/13/2005 | EP1552024A2 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 07/13/2005 | EP1552023A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 07/13/2005 | EP1552022A2 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid |
| 07/13/2005 | EP1552021A1 Type i interferon-inducible proteins to detect viral infection |
| 07/13/2005 | EP1552020A2 Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis |
| 07/13/2005 | EP1552019A2 Cancer diagnostics and prognostics |
| 07/13/2005 | EP1552018A2 Methods and compositions relating to gene silencing |
| 07/13/2005 | EP1552017A1 Apparatus and methods for detecting dna in biological samples |
| 07/13/2005 | EP1552016A2 Methods for vaccine identification and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the herpesvirus family |
| 07/13/2005 | EP1552015A2 Method for drying dye-terminator sequencing reagents |
| 07/13/2005 | EP1552014A2 Diagnostic and therapeutic means for kidney stone related pathologies |
| 07/13/2005 | EP1552013A1 Microfluidic device including purification column with excess diluent, and method |
| 07/13/2005 | EP1552012A2 Susceptibility gene for human stroke; methods of treatment |
| 07/13/2005 | EP1552011A2 Photonic signal reporting of electrochemical events |
| 07/13/2005 | EP1552010A2 Strategies for gene expression analysis |
| 07/13/2005 | EP1552009A2 Method for identifying cellular growth inhibitors |
| 07/13/2005 | EP1552008A1 Microparticle based signal amplification for the detection of analytes |
| 07/13/2005 | EP1552007A1 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry |
| 07/13/2005 | EP1552006A2 Method and means for quantitative analysis of the number of molecules coding for different genes in cells |
| 07/13/2005 | EP1552005A1 Apparatus and method for isolating a nucleic acid from a sample |
| 07/13/2005 | EP1552004A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 07/13/2005 | EP1552003A1 Methods to assess quality of microarrays |
| 07/13/2005 | EP1552002A2 Aptamer-toxin molecules and methods for using same |
| 07/13/2005 | EP1552001A2 Methods and compositions for detecting targets |
| 07/13/2005 | EP1552000A2 Marker gene |
| 07/13/2005 | EP1551999A1 Arrays of electrodes coated with molecules and their production |
| 07/13/2005 | EP1551998A2 Method for diagnosing non-small cell lung cancers |
| 07/13/2005 | EP1551997A1 Assay methods for detection of a virus in an avian tissue sample |
| 07/13/2005 | EP1551996A1 Association of the h2 haplotype of the p2y12 receptor with an increased risk for thrombosis and peripheral arterial disease |
| 07/13/2005 | EP1551995A2 Complexity management of genomic dna by locus specific amplication |
| 07/13/2005 | EP1551994A2 Means of detecting neurodegenerative processes and applications of same |
| 07/13/2005 | EP1551993A1 A method for screening for an antimicrobial polypeptide |
| 07/13/2005 | EP1551992A2 Screening molecules with anti-prion activity: kits, methods and screened molecules |
| 07/13/2005 | EP1551991A2 Functional cardiomyocytes from human embryonic stem cells |
| 07/13/2005 | EP1551990A2 Diagnosis and treatment of chemoresistant tumors |
| 07/13/2005 | EP1551989A1 Rapid coliform detection system |
| 07/13/2005 | EP1551988A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 07/13/2005 | EP1551978A2 Nell-1 enhanced bone mineralization |
| 07/13/2005 | EP1551976A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551965A2 Short enzyme donor fragment |
| 07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/13/2005 | EP1551962A2 Mitotic kinesin binding site |
| 07/13/2005 | EP1551960A2 Hepatitis c viral-like particle purification |
| 07/13/2005 | EP1551959A2 Modulators of chloride intracellular channel 1 protein signaling |
| 07/13/2005 | EP1551957A2 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 07/13/2005 | EP1551949A1 Device for the amplification of dna, comprising a microwave energy source |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551864A1 Substrate for tafi (a) |
| 07/13/2005 | EP1551627A2 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same |
| 07/13/2005 | EP1551439A2 Improved systems and methods for analysis of protein post-translational modification |
| 07/13/2005 | EP1551437A2 Methods and compositions for detecting cancers |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551383A2 Methods for preventing and treating microbial infections by modulating transcription factors |
| 07/13/2005 | EP1551221A2 Nucleic acid compositions for stimulating immune responses |
| 07/13/2005 | EP1488002A4 Methods to increase nucleotide signals by raman scattering |
| 07/13/2005 | EP1430143A4 Stabilization of t4 endonuclease v |
| 07/13/2005 | EP1390710A4 Amplification and detection of $i(mycoplasma pneumoniae) |
| 07/13/2005 | EP1383923A4 High-fidelity dna sequencing using solid phase capturable dideoxynucleotides and mass spectrometry |
| 07/13/2005 | EP1360327A4 Method for identifying genes regulating desired cell phenotypes |
| 07/13/2005 | EP1292700A4 Enzyme detection and measurement |
| 07/13/2005 | EP1266039B1 Method and kit for the screening, the detection and/or the quantification of transcriptional factors |
| 07/13/2005 | EP1036332B1 Multiple assay method |
| 07/13/2005 | EP1023598B1 Chemical indicator and its use |
| 07/13/2005 | EP0804548B1 Patched genes and their use |
| 07/13/2005 | EP0553234B2 Luciferase compositions and methods |
| 07/13/2005 | EP0394296B2 Assay of a body fluid for measuring bone resorption |
| 07/13/2005 | CN1639832A A plasma mass spectrometer |
| 07/13/2005 | CN1639575A In vitro model for priocidal activity |
| 07/13/2005 | CN1639574A Serological assay for neospora caninum |
| 07/13/2005 | CN1639571A Population based assessments and means to rank the relative immunogenicity of proteins |
| 07/13/2005 | CN1639570A Proteins with repetitive bacterial-ig-like (BIG) domains present in leptospira species |
| 07/13/2005 | CN1639563A Substrate determining method |
| 07/13/2005 | CN1639358A Multiple virus replicon culture systems |
| 07/13/2005 | CN1639357A Method for detecting human papillomarvirus mRNA |
| 07/13/2005 | CN1639356A Method for labelling and fragmenting DNA |
| 07/13/2005 | CN1639355A Double and triple readout assay systems |
| 07/13/2005 | CN1639352A Amplifying repetitive nucleic acid sequences |
| 07/13/2005 | CN1639343A Method for detection of leptin receptor ligands |
| 07/13/2005 | CN1639334A Novel method of highly sensitive nucleic acid analysis |
| 07/13/2005 | CN1639326A High throughput system for producing recombinant viruses using site-specific recombination |
| 07/13/2005 | CN1639324A Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/13/2005 | CN1639320A Cold shock inducible expression and production of heterologous polypeptides |
| 07/13/2005 | CN1639206A Biosensor membranes composed of polymers containing heterocyclic nitrogens |
| 07/13/2005 | CN1639189A Cell apoptosis regulating protein related with heart failure |
| 07/13/2005 | CN1639185A Cancer-associated epitope |